MyFinsight
Home
Blog
About
Long-term investments
$1,020,896K
(-12.38%↓ Y/Y)
Property and equipment,
net
$260,390K
(7.48%↑ Y/Y)
Other assets
$192,557K
(102.13%↑ Y/Y)
Operating lease
right-of-use assets
$110,178K
(28.64%↑ Y/Y)
Restricted cash
$1,465K
(11.07%↑ Y/Y)
Short-term investments
$1,303,648K
(-3.77%↓ Y/Y)
Cash and cash
equivalents
$183,190K
(-40.28%↓ Y/Y)
Prepaid expenses and
other current assets
$65,830K
(21.13%↑ Y/Y)
Total noncurrent
assets
$1,585,486K
(-0.26%↓ Y/Y)
Total current assets
$1,552,668K
(-9.51%↓ Y/Y)
Total assets
$3,138,154K
(-5.06%↓ Y/Y)
Total liabilities and
stockholders' equity
$3,138,154K
(-5.06%↓ Y/Y)
Total stockholders'
equity
$2,757,942K
(-10.20%↓ Y/Y)
Total liabilities
$380,212K
(62.46%↑ Y/Y)
Accumulated deficit
-$2,759,871K
(-62.77%↓ Y/Y)
Accumulated other
comprehensive (gain) loss
-$7,546K
(-299.89%↓ Y/Y)
Additional paid-in capital
$5,525,211K
(15.86%↑ Y/Y)
Total current
liabilities
$271,277K
(75.60%↑ Y/Y)
Operating lease
liabilities long-term
$108,935K
(36.95%↑ Y/Y)
Common stock, 0.001 par
value 500,000,000...
$148K
(11.28%↑ Y/Y)
Accrued contract
manufacturing expenses
$125,298K
(69.95%↑ Y/Y)
Accounts payable
$100,919K
(221.25%↑ Y/Y)
Accrued expenses
$24,728K
(-23.24%↓ Y/Y)
Accrued compensation
$13,822K
(27.63%↑ Y/Y)
Operating lease
liabilities current
$6,510K
(3.30%↑ Y/Y)
Back
Back
Balance Sheet
Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. (PCVX)
source: myfinsight.com